Data presented at ICAD-2008 show Suven’s 5-HT6 antagonist SUVN-502 to be effective in preclinical models of Alzheimer’s
Filed under: gpcr | Tagged: 5-ht6, 5ht6, antagonist, Preclinical, Research, suven
Name (required)
E-mail (will not be published) (required)
Website
Notify me of follow-up comments via email.
Notify me of new posts via email.
